Kato (Hong Kong) Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5216P1063
HKD
0.45
-0.01 (-1.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
317.11
271.33
408.30
320.34
256.53
196.10
174.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
317.11
271.33
408.30
320.34
256.53
196.10
174.75
Raw Material Cost
210.47
175.87
222.87
176.59
133.38
110.94
105.54
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
128.19
103.08
133.50
119.79
82.44
61.73
55.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.58
12.07
8.79
7.94
5.88
4.17
0.58
Selling and Distribution Expenses
40.80
38.22
45.82
29.74
24.59
18.39
10.05
Other Expenses
-14.38
-11.52
-14.23
-12.77
-8.83
-6.59
-5.64
Total Expenditure (Excl Depreciation)
251.27
214.09
268.69
206.33
157.97
129.33
115.59
Operating Profit (PBDIT) excl Other Income
65.8
57.199999999999996
139.60000000000002
114
98.6
66.8
59.2
Other Income
6.71
10.12
2.14
5.79
1.05
1.60
0.02
Operating Profit (PBDIT)
121.84
115.00
186.39
156.37
131.63
96.41
64.96
Interest
15.58
12.07
8.79
7.94
5.88
4.17
0.58
Exceptional Items
-25.00
18.61
20.51
5.30
0.24
-5.51
-11.10
Gross Profit (PBDT)
106.64
95.46
185.43
143.75
123.15
85.16
69.21
Depreciation
49.28
47.64
44.64
36.57
32.02
28.05
5.78
Profit Before Tax
31.98
73.90
153.46
117.17
93.98
58.69
47.50
Tax
10.85
9.79
27.68
18.08
14.48
10.82
9.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.88
64.19
126.15
98.94
79.87
47.87
37.88
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21.88
64.19
126.15
98.94
79.87
47.87
37.88
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.76
-0.08
-0.37
0.15
-0.37
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.13
64.11
125.78
99.09
79.50
47.87
37.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
436.75
434.29
372.63
291.53
232.63
192.67
28.37
Earnings per share (EPS)
0.02
0.06
0.13
0.1
0.08
0.05
0.04
Diluted Earnings per share
0.02
0.06
0.13
0.1
0.08
0.05
0.04
Operating Profit Margin (Excl OI)
20.76%
21.1%
34.19%
35.59%
38.42%
34.05%
33.86%
Gross Profit Margin
25.63%
44.79%
48.52%
47.99%
49.12%
44.23%
30.49%
PAT Margin
6.9%
23.66%
30.9%
30.88%
31.14%
24.41%
21.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 16.88% vs -33.55% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -67.08% vs -49.05% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 9.72% vs -43.08% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 28.93% vs 37.50% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Kato (Hong Kong) Holdings Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
317.11
227.58
89.53
39.34%
Other Operating Income
0.00
0.00
0.00
Total Operating income
317.11
227.58
89.53
39.34%
Raw Material Cost
210.47
148.93
61.54
41.32%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
128.19
74.14
54.05
72.90%
Power Cost
0
0
0.00
Manufacturing Expenses
15.58
3.80
11.78
310.00%
Selling and Distribution Expenses
40.80
61.17
-20.37
-33.30%
Other Expenses
-14.38
-7.79
-6.59
-84.60%
Total Expenditure (Excl Depreciation)
251.27
210.11
41.16
19.59%
Operating Profit (PBDIT) excl Other Income
65.85
17.48
48.37
276.72%
Other Income
6.71
1.34
5.37
400.75%
Operating Profit (PBDIT)
121.84
65.62
56.22
85.68%
Interest
15.58
3.80
11.78
310.00%
Exceptional Items
-25.00
2.01
-27.01
-1,343.78%
Gross Profit (PBDT)
106.64
78.65
27.99
35.59%
Depreciation
49.28
46.81
2.47
5.28%
Profit Before Tax
31.98
17.02
14.96
87.90%
Tax
10.85
0.66
10.19
1,543.94%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
21.88
16.37
5.51
33.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
21.88
16.37
5.51
33.66%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-0.76
0.00
-0.76
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.13
16.37
4.76
29.08%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
436.75
19.50
417.25
2,139.74%
Earnings per share (EPS)
0.02
0.02
0.00
Diluted Earnings per share
0.02
0.02
0.00
Operating Profit Margin (Excl OI)
20.76%
7.68%
0.00
13.08%
Gross Profit Margin
25.63%
28.05%
0.00
-2.42%
PAT Margin
6.90%
7.19%
0.00
-0.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 31.71 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 16.88% vs -33.55% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 2.11 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -67.08% vs -49.05% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.51 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 9.72% vs -43.08% in Mar 2024

Annual - Interest
Interest 1.56 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 28.93% vs 37.50% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.76%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024